Mechanosensitive Ca2+-permeable channels in human leukemic cells: Pharmacological and molecular evidence for TRPV2  by Pottosin, Igor et al.
Biochimica et Biophysica Acta 1848 (2015) 51–59
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemMechanosensitive Ca2+-permeable channels in human leukemic cells:
Pharmacological and molecular evidence for TRPV2Igor Pottosin a, Iván Delgado-Enciso b, Edgar Bonales-Alatorre a, María G. Nieto-Pescador a,
Eloy G. Moreno-Galindo a, Oxana Dobrovinskaya a,⁎
a Center for Biomedical Research, University of Colima, Colima, Mexico
b School of Medicine, University of Colima, Colima, MexicoAbbreviations: 2-APB, 2-Aminoethoxydiphenyl bora
anthranilic acid; K2P channels, Two-pore domain K+ cha
channel;RR,Rutheniumred;TRP,Transientreceptorpotent
tential canonical; TRPM, Transient receptor potentialmela
potential polycystic; TRPV, Transient receptor potential va
⁎ Corresponding author at: Centro Universitario de
Universidad de Colima, Av. 25 de Julio 965, Villa San
Mexico. Tel.: +52 312 3161000x47454; fax: +52 312 31
E-mail address: oxana@ucol.mx (O. Dobrovinskaya).
http://dx.doi.org/10.1016/j.bbamem.2014.09.008
0005-2736/© 2014 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 7 May 2014
Received in revised form 12 September 2014
Accepted 15 September 2014
Available online 28 September 2014
Keywords:
T-lymphocyte
Plasma membrane stretch
Mechanosensitive channel
Calcium
TRPV2Mechanosensitive channels are present in almost every living cell, yet the evidence for their functional presence
in T lymphocytes is absent. In this study, by means of the patch-clamp technique in attached and inside-out
modes, we have characterized cationic channels, rapidly activated bymembrane stretch in Jurkat T lymphoblasts.
The half-activationwas achieved at a negative pressure of ~50mmHg. In attachedmode, single channel currents
displayed an inward rectiﬁcation and the unitary conductance of ~40 pS at zero command voltage. In excised
inside-out patches the rectiﬁcation was transformed to an outward one. Mechanosensitive channels weakly
discriminated between mono- and divalent cations (PCa/PNa ~ 1) and were equally permeable for Ca2+ and Mg2+.
Pharmacological analysis showed that the mechanosensitive channels were potently blocked by amiloride
(1 mM) and Gd3+ (10 μM) in a voltage-dependent manner. They were also almost completely blocked by
ruthenium red (1 μM) and SKF 96365 (250 μM), inhibitors of transient receptor potential vanilloid 2 (TRPV2)
channels. At the same time, the channels were insensitive to 2-aminoethoxydiphenyl borate (2-APB, 100 μM) or
N-(p-amylcinnamoyl)anthranilic acid (ACA, 50 μM), antagonists of transient receptor potential canonical (TRPC)
or transient receptor potential melastatin (TRPM) channels, respectively. Human TRPV2 siRNA virtually abolished
the stretch-activated current. TRPV2 are channels with multifaceted functions and regulatory mechanisms, with
potentially important roles in the lymphocyte Ca2+ signaling. Implications of their regulation by mechanical stress
are discussed in the context of lymphoid cells functions.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Living cells respond to a variety of mechanical stimuli, from osmotic
stress to localmechanical deformations of themembrane. The sequence
of events activated by initial mechanical stimulation and leading to the
speciﬁc cellular response is the subject of intensive studies in different
types of cells. Nowadays, it is well established that the transduction of
mechanical stimuli to electrical and, in some cases, also to Ca2+ signals
is mediated by mechanosensitive channels (MSCs), which are found in
all kingdoms, including prokaryotes (for a review see [54,22]). In mam-
mals, three groups of channels were proved to showmechanosensitive
properties: degenerins or epithelium Na+ channels (ENaC), some two-te; ACA, N-(p-amylcinnamoyl)
nnels; MSC, Mechanosensitive
ial;TRPC,Transientreceptorpo-
statin; TRPP, Transient receptor
nilloid.
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61129.pore domain K+-selective (K2P) channels, and certain members of
the transient receptor potential (TRP) channels family [39]. In addition,
recently discovered Piezo channels appear to form non-selective
(Ca2+ ~ Mg2+ ~ Na+ ~ K+) rapidly-inactivating mechanosensitive cat-
ion channels or be a part of such channel [11,17,48]. TRPs, which were
proved to be directly or indirectly gated bymechanical stretch, namely,
TRPC 1 and 6, TRPV1, 2 and 4, TRPM3, 4, and 7, TRPP 1 and 2, and TRPA1,
form cationic MSC in most cases only weakly discriminating between
Na+ and Ca2+ [39].
Very little is known about MSC in lymphoid cells. However, for a
variety of physiological processes taking place in lymphocytes, the
ability to respond rapidly tomechanical stimulation seems to be crucial.
Indeed, circulating lymphocytes are affected by ﬂuid ﬂow, variations in
osmolarity and blood pressure. They also change their shape during
extravasation and inﬁltration of tissues. Antigen recognition, lympho-
cyte maturation and activation are vitally important processes, where
cell–cell interactions occur. During direct contacts, cells may undergo
mechanical deformation and membrane stretch. For distant indirect
interactions, lymphocytes produce and secret the variety of lymphokines.
It was shown recently that mechanical stress may provoke lymphokine
release [29].
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Swelling can be sensed by volume-sensitive outward-rectifying Cl−
channels, VSOR [36,34] and regulated volume decrease is achieved by
parallel operation of Cl− and K+ channels, with a potential contribution
of Kv1.3, KCa3.1 and different K2P channels [6,4]. Notably, regulated
volume decrease is Ca2+-independent in mature T lymphocytes, but
in thymocytes and Jurkat lymphoblasts it is regulated by swelling-
activated Ca2+ inﬂux, which is 100-times less sensitive to Gd3+ as
compared to a dominant lymphocyte Ca2+-inﬂux channel, CRAC [53].
Potentially, volume decrease can be mediated by some Ca2+-permeable
channels from the TRP family. In T-cells, the expression of different
TRPC (1, 3, 6), TRPM (2, 4, 7), and TRPV (1, 2) were detected. TRPC6
was not detected in Jurkat; instead, the expression of TRPC4, TRPC5, and
TRPV6, which are rarely present in T-cells from healthy donors, was
reported [67]. Of them, only functional roles of TRPM (4, 7 and to a less
extent, 2) were revealed for T-cells (for a review see [6,15]). TRPM4 is
unique channel with a very low Ca2+ permeability, so it cannot be
involved in the stretch-activated Ca2+ inﬂux. Yet, multiple TRP family
members still left, which potentially encode MSC in T-cells and lympho-
blasts. This study was undertaken to check for the presence of the TRP-
like MSCs in Jurkat cells and to verify their identity on the basis of ionic
selectivity and conductance, pharmacological proﬁle and, eventually, by
means of small interfering RNA.
2. Materials and methods
2.1. Cell preparation and culture condition
Jurkat cells (clone E6-1) were kindly provided by Dr. Yvonne
Rosenstein (Instituto de Biotecnología, UNAM, México). Cells were cul-
tured in Advanced RPMI 1640 medium supplemented with 5% heat-
inactivated fetal calf serum, 100 U/ml penicillin, 100 μg/ml streptomy-
cin, and 1% of GlutaMAX™ (all from Invitrogene, Carlsbad, CA, USA) at
37 °C in a humidiﬁed atmosphere (5% CO2, 95% air). Cells were main-
tained in the logarithmic growth phase by daily medium refreshment.
2.2. TRPV2 silencing by small interfering RNA (siRNA)
siRNA transfection experiments were carried out using as a starting
point the Supplementary Protocol for Jurkat cells provided by Quiagen.
The protocol was optimized for our conditions to achieve bothmaximal
cell survival and transfection efﬁciency. Resulting protocol was as
follows: 1 × 106 cells in 250 μl of Advanced RPMI 1640mediumwithout
serum and antibiotics were transfected with 1.75 μl of Lipofectamine
2000 transfection reagent (Life Technologies) and 1250 ng of
ﬂuorescein-coupled small interfering RNA (siRNA) against TRPV2
(FlexiTube siRNA S102781359 from Quiagen), the concentration value
being inside the range for cationic lipids mediated siRNA transfection
in Jurkat cells recommended by Quiagen (140–562 ng/100 μl). siRNA
sequenceswere: sense strand 5′-GAGGAUCUUUCCAACCACATT-3′, anti-
sense strand 5′-UGUGGUUGGAAAGAUCCUCTG-3′. Additionally, a nega-
tive siRNA-control with scrambled sequence (siRNA 1027310 from
Quiagen) was used to transfect cells in the same conditions. After 5 h
incubation at 37 °C in a humidiﬁed atmosphere (5% CO2, 95% air), the
medium with transfection complexes was replaced for 250 μl Advanced
RPMI 1640 medium supplemented with 2.5% heat-inactivated fetal
calf serum, 100 U/ml penicillin, 100 μg/ml streptomycin, and 1% of
GlutaMAX™ (all from Invitrogen). The cells were allowed to recover
during at least 1 h, and the effect of silencingwas tested by patch-clamp
in cell-attached conﬁguration and qRT-PCRduring the next 6 h. Cell sur-
vival was estimated by trypan blue exclusion test. Transfection efﬁcien-
cy was analyzed and the images were obtained by confocal microscopy
using an LSM 700 system (Carl Zeiss) coupled to an inverted
Observer.Z1 microscope, equipped with 40× oil-immersion objectives,
488 nm laser, and ZEN imaging software. The settings were: laser
power 2%, pinhole Φ = 1.00 AU; detector gain = 685; line step: 1;scan speed: 6; data depth: 16 bit; mode: line; method: mean; scan
number: 2; zoom: 1.2.3. Electrophysiology
Patch-clamp experiments were performed in attached and inside-
out conﬁgurations using an Axopatch 200A Integrating Patch-clamp
ampliﬁer (Axon Instruments). Patch pipettes were pulled from Kwik-Fil
1B150F-4 capillaries (World Precision Instruments, Sarasota, FL, USA)
and ﬁre-polished. Patch electrodes were ﬁlled with a solution containing
(in mM): 134 KCl, 2 MgCl2, 1 CaCl2, 10 EGTA, 10 HEPES–KOH (pH 7.4).
The resistance of patch electrodes ﬁlled with this solution was 3–5 MΩ.
For cell-attached recordings, bath solution (“160 NaCl”) contained
(in mM): 150 NaCl, 5 KCl, 1 MgCl2, 2.5 CaCl2, and 10 HEPES–NaOH
(pH 7.4). For ion selectivity measurements in the inside-out conﬁgura-
tion, different bath solutions were implemented. One was identical to
the bath solution described above or 10 times diluted, “16 NaCl.” K+
to Cl− selectivity was evaluated with a bath, containing (in mM): 9
KCl, 10 HEPES–KOH (pH 7.4). For Na+/Ca2+ or Na+/Mg2+ selectivity
measurements, bath solution was the same as for cell-attached mea-
surements (“160 NaCl”), whereas pipette solution contained (in mM):
50 CaCl2 or MgCl2, 5 HEPES–Ca(OH)2 (pH 7.4). Osmolality of all solu-
tions was adjusted to 310 mOsm. For mechanical patch stimulation, a
constant negative pressure to the patch pipette interior was applied
manually and its magnitude was veriﬁed with a portative manometer.
Records were low-pass ﬁltered at 5 kHz, digitized using a DigiData
1200 Interface (Axon Instruments, Foster City, CA), transferred to a
personal computer and analyzed using the pClamp 6.0 software package
(Axon Instruments, Foster City, CA).
In TRPV2 silencing experiments, epiﬂuorescence was used to distin-
guish siRNA transfected (ﬂuorescein-positive) and non-transfected
cells. To prove the effect of TRPV2 silencing on stretch-activated current,
electrophysiological records were performed on membrane patches
from siRNA positive and negative cells, assayed in a random order.
Three independent transfection experiments were realized. Simulta-
neously, knockdown efﬁciency was determined by single cells qRT-
PCR analysis. Single cells were recollected by aspiration during patch-
clamp experiments, using glass micropipettes with a tip opening ca.
20 μm fabricated on the P-97 Flaming/Brown Micropipette Puller
(Sutter Instruments, Novato, CA, USA).2.4. Single-cell qRT-PCR
Cells were submitted to single-cell one-step real-time duplex RT-
PCR analyses using Roche Light Cycler version 1.5. The QuantiFast
Probe assay RT-PCR Plus Kit for dual detection of TRPV2 and GAPDH
(Quiagen) was used. Corresponding QuantiFast Probes labeled with
different ﬂuorochromes were: TRPV2/FAM (Cat. No QF00207102) and
GAPDH/MAX (Cat No QF00531132). Experimental procedures followed
the manufacturer's protocol. Cells were emptied directly into the one-
step qRT-PCR reaction, without RNA puriﬁcation. Before the initiation
of the cDNA synthesis, samples were incubated at 80 °C over 5 min as
described elsewhere [3]. Cells transfected with siRNA against TRPV2,
non-transfected cells, and siRNA negative controls (cells, transfected
with siRNA 1027310 from Quiagen) were assayed. To determine rela-
tive expression of the mRNAs, real-time RT-PCR data were analyzed
by the comparative ΔΔCT method as previously described [58].2.5. Data analysis
Data are reported as mean ± SEM. Where appropriate paired or
unpaired Student's t test was used to evaluate statistical difference. A
two-tailed probability value of less than 0.05 (p b 0.05) was considered
statistically signiﬁcant.
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3.1. Membrane stretch activates Ca2+-permeable cation channels in
Jurkat cells
Jurkat cells easily formhigh resistance seals (10–40GΩ)with a patch
pipette after application of light suction (see an example in Fig. 1b,
where the leak resistance was 17 GΩ). Attached patches, inspected im-
mediately after gigaseal formation often show some residual channels'
activity, which normally ceased after 1–2 min. Then, ramp wave proto-
cols were applied in a following sequence: three 1 s-episodes without
suction, further three ramps under negative pressure (60 mm Hg),
followed by four ramps at zero pressure. Alternatively, negative pressure
was applied for few seconds at a ﬁxed voltage. Mechanical stimulation
caused a rapid activation of several mechanosensitive channels (MSCs)
in up to 80% of inspected patches (Fig. 1a, b). Their activity did not
show a signiﬁcant inactivation within few seconds of stimulation, yet
after turning off the suction, channels' activity displayed a relatively
slow deactivation (Fig. 1a). Deactivation of the MSC activity was much
faster (b1 s) while running a sequence of voltage ramps. Thus, beforeFig. 1.Membrane stretch evokes activation of ion channels in cell-attached patches. a. Exam-
ples of an on-cell recording of the activity of mechanosensitive channels in Jurkat cells. After
obtaining a tight seal with cell membrane, command voltage was clamped to −50 mV
(cytosol minus exterior) and application of a suction pulse (60mmHg) as indicated resulted
in the rapid and reversible opening of several mechanosensitive channels. b. Response to a
ramp-wave voltage protocol (shown in the inset); ﬁrst three ramps were applied without
suction (no channel activity), followedby three rampsunder application of negative pressure
of 60 mmHg, and further four ramps with a pressure released (cessation of the channel ac-
tivity). Gray traces are leak currents (with zero channel activity). c.Toobtainunitary current–
voltage (I/V) relationships for mechanosensitive channels, rampswith channel activity were
used and averaged leak current was subtracted; resulting I/V curves were further divided by
a number of open channels, using resolved single channel records, as one in a for a proper
scaling. Data are presented asmean±SE, data for eight individual Jurkat cellswere averaged.and after application of the suction normally only leak currents were
recorded (Fig. 1b). After subtraction of leak currents and normalization
of resulting I/V curves by dividing them through a number of visible
channels, single channel I/V relations were obtained (Fig. 1c). As can
be seen from the ﬁgure, single channel currents reversed at potentials
close to the resting membrane voltage (zero command voltage) and
displayed a notable inward rectiﬁcation. Stable activity of MSCs can be
repeatedly reproduced over at least 15 min in cell-attached conﬁgura-
tion without a notable rundown. Yet, patch excision resulted in a faster
rundown, especially in the presence of high (millimolar) divalent cation
concentrations at eithermembrane side.Wewere unable to induceMSC
activity in outside-out patches. Therefore, to assay the dose–response
dependence of the MSC activity and effects of external drugs we have
used exclusively the cell attached conﬁguration, whereas for the single
channel ion selectivity measurements we have used inside-out patches.
The latter allowed control of ionic conditions at both membrane sides.
To reveal mechanosensitivity, we have applied variable negative
pressure to the patch-pipette interior at ﬁxed potential of −50 mV
(Fig. 2). As can be seen, MSC activity could be detected at pressure as
low as 20 mm Hg, and saturated at negative pressures N80 mm Hg by
absolute value, with a midpoint around 50 mm Hg.
MSC in Jurkat cells revealed a high degree of the K+/Cl− selectivity as
evidenced by the data in Fig. 3b. It has also a comparable permeability for
K+andNa+ (Fig. 3a) or forNa+andCa2+orMg2+ (Fig. 3c). Interestingly,
in inside-out conﬁguration, single MSC current–voltage relations
displayed an outward rectiﬁcation (Fig. 2a, b), compared to the inward
rectiﬁcation in on-cell patches (Fig. 1c).Fig. 2. Evaluation of the mechanosensitivity of stretch-activated channels in Jurkat cells.
Example of channels' activation at ﬁxed voltage (−50 mV) in response to increasingly
higher negative pressure, applied and relieved as indicated by arrows. Normalized channel
activity as a function of applied pressure, responses were normalized to that at 100 mm
Hg; data for seven individual cells were averaged and presented as means ± SE. Fitting
yielded a midpoint for the response at the pressure of 52 ± 2 mm Hg.
Fig. 3. Selectivity of the mechanosensitive channels in Jurkat cells. All measurements were
done on isolated inside-out patches; channel-mediated current was evaluated by applying
voltage-ramp protocol as described in Fig. 1b, c. a, b. Stretch-activated channels were selec-
tive for cations against Cl− but did not differentiate between K+ andNa+. Cationic selectivity
is evidence by a positive shift of reversal potential upon a 10-fold dilution of the bath; mind
the opposite shift of equilibrium potential for Cl−. On the other hand, zero reversal potential
at bi-ionic conditions, KCl against approximately the same concentration ofNaCl (gray curve)
implied equal permeability for K+ and Na+. In b, reversal potential of the single channel
current approached EK+ and is far fromECl−, implying a highK+/Cl− selectivity. c. Stretch ac-
tivated channels donot differentiate betweenNa+(160mMin thebath) anddivalent cations
(50 mM of CaCl2, black curve, or MgCl2, gray curve, in the bath). For each trace, unitary I/V
curves from ﬁve to nine individual cells were averaged.
Fig. 4. Voltage dependent block of the stretch-activated channels by amiloride and Gd3+.
In a, b control and test measurements weremade by patching the same cell with a pair of
pipettes, with or without the drug. I/V curves obtained from a single cell normally
reﬂected multiple mechanosensitive channels openings in a cell-attached patch; ﬁve
separate cells were averaged for a, and nine for b. c. Relative currents, in the presence of
drug to that in control, as a function of membrane voltage, were ﬁtted with a modiﬁed
Boltzmann relation, yielding mean voltage sensitivity (zδ) value of 0.64 and 0.52 for
amiloride andGd3+, respectively.Mind a small but signiﬁcant offset of the relative current
at large negative voltages.
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In continuation, we performed the pharmacological analysis of the
MSC in Jurkat cells. To do this, we have introduced a blocker into the
patch-pipette (in case of Gd3+ and ruthenium red (RR), EGTA and diva-
lent cations were excluded from the standard pipette solution). Tomake
a comparisonwith a control feasible and tominimize a difference, caused
by a variation of channels' expression in different cells, we took an
advantage of a relatively large size of lymphoblasts, so that each cell
could be patched twice (up to ﬁve times), with different patch-pipettescontaining or not the blocker of interest. When multiple patching was
not possible with the same cell for any reason (e.g. cell disruption),
these results were discarded. The ﬁrst two blockers used were amiloride,
a non-speciﬁc blocker of epithelium Na+ channels and antiporters, as
well as of some MSC and TRP channels (see [33,12] and the references
therein), andGd3+, a blocker of a variety of non-selective cation channels.
Both drugs blocked the MSC mediated current in a voltage-dependent
manner, with a muchmore pronounced effect on the current at negative
membrane potentials (Fig. 4a, b). As both blockers are positively charged,
this implied that their binding site lies well within a voltage drop across
the membrane. Moreover, blockage at negative potentials was not
complete as evidenced by small, but signiﬁcant offset of the relative
current (Fig. 4b). This observation suggests that both cations may be
forced to pass across the whole MSC pore at large negative potentials.
Fig. 5. Pharmacological analysis of the channel-mediatedmechanosensitive currents in Jurkat cells. Ramp-wave protocols were applied, and currents were evoked by 60mmHg negative
pressure and subtracted by leak currents, measured before and after the pressure application. All measurements were performed on cell-attached patches, each control and test measure-
mentwas doneby patching a single cellwith a pair of pipettes,without andwith indicated concentration of the drug, and so repeated for eachdrug onﬁve to six cells, data aremeans±SE.
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blocked by RR (1 μM), inhibitor of different Ca2+-permeable channels
(including all members of TRPV family) and transporters, and also
by SKF 96365, blocker of store- and receptor operated Ca2+ entry
as well as of some TRP channels [65,19,21]. At the same time, 2-
aminoethoxydiphenyl borate (2-APB), initially used as a blocker of inosi-
tol 1,4,5-trisphosphate receptor and store-operated Ca2+ entry, which
also blocks all members of TRPC and TRPM subfamilies (see [19]; and
the references therein) was completely inefﬁcient (Fig. 4). N-(p-
amylcinnamoyl)anthranilic acid (ACA), inhibitor of phospholipase A2,
which directly blocks a variety of TRP channels [20] was also inefﬁcient.
Taken together, thepharmacological proﬁle of the channel of interest
better matches the characteristics of the TRPV2 channel (see Discussion
for more details). Considering also that in human lymphocytes TRPV2 is
the most abundantly expressed among TRPV family members [60], the
effect of TRPV2 silencing on stretch-activated current was evaluated in
the subsequent set of experiments.3.3. TRPV2 silencing with siRNA virtually abolished stretch-activated current
Jurkat belong to “hard-to-transfect” cells. In our hands, the efﬁciency
of siRNA transfection achieved 20–30% (Fig. 6a) without affecting cell
survival (98–100%). Patch-clamp and single cell qRT-PCR experiments
were performed between 6 and 12 h after the start of transfection. In
non-transfected cells, the occurrence of mechanosensitive current was
detected in 82% of cells (as compared to 80–90% routinely observed
for Jurkat cells in the logarithmic growth phase), whereas only 18% of
cells with a visible green ﬂuorescence displayed a detectable currentin attached patches in response to suction. TRPV2 mRNA expression
and stretch-activated current were strongly inhibited in TRPV2 siRNA
transfected cells (Fig. 6b, c).4. Discussion
Jurkat cells, the experimental model of the present study, show
some differences in ion channel expression, when compared to healthy
mature T cells [6]. Considering that leukemic cell lines are derived from
different subsets of immature T cells where additional genetic lesions
occurred [64], these differences may reﬂect bothmaturation and leuke-
mogenesis processes. However, stretch-activated channels have been
shown to be present ubiquitously in mammalian cells [54,22]. Although
healthy lymphocytes and leukemic cells are exposed to mechanical
stimuli constantly during the performance of their physiological func-
tions, electrophysiological studies of stretch-activated channels on this
type of cell are scarce [61]. To the best of our knowledge, the question
concerning with the presence of mechanically gated ion channels in
lymphoid T cells has never been addressed. At the same time, quantita-
tive RT-PCR technique revealed the expression of several members of
the three potentially mechanosensitive subfamilies TRPC, TRPV and
TRPM in human lymphocytes and Jurkat cells [67]. It should be noted
that only for a couple of TRP channels relatively selective agonists or
blockers are available, so that the channel identifying strategy in the
case of this family cannot be based on the usage of single speciﬁc
drugs. Rather, a variety of nonspeciﬁc blockers, like RR, binding to the
most of Ca2+-binding sites (e.g. of calmodulin or those within a large
variety of Ca2+ and Ca2+-permeable channels and transporters) or 2-
Fig. 6. Effect of TRPV2 siRNA transfection on TRPV2mRNA expression and stretch-activated current in Jurkat cells. a. Visualization of efﬁciency in TRPV2 siRNA uptake by Jurkat cells in culture.
The images of living cells are obtained after 5 h of incubation with ﬂuorescein-labeled TRPV2 siRNA. Brightly ﬂuorescent green cells internalized the siRNA. Phase contrast (left), ﬂuoresceine
(middle) and merged (right) images are presented. Scale bar: 20 μM. b. Relative expression of TRPV2 mRNA normalized to GAPDHmRNA expression. TRPV2 siRNA transfected (n = 3) and
non- transfected (n=3) cellswere analyzed by single cell real-time qRT-PCR. Data aremeans±SE; **p b 0.005. c.Amplitude of the stretch-activated current in cell-attached patcheswas eval-
uated at−100 mV in TRPV2 siRNA transfected (n = 22) and non-transfected (n = 23) cells. Transfected and non-transfected cells present in each of three independent preparations were
assayed in a random order. Data are means ± SE; ***p b 0.001. In b and c, negative siRNA controls were comparable to non-transfected cells (data not shown).
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lantanides, generic blockers of non-selective cation channels, are used
instead [68]. Taken the advantage of existing differences in pharmacolog-
ical proﬁles between diverse TRP channels, e.g. lantanides ions instead ofTable 1
Comparative pharmacology of TRP channels reported for Jurkat cells and MSC described in Jur
Gd3+ (La3+) 2-APB ACA Ruthenium red (R
TRPC1 + + ND ±
TRPC3 + + ND ±
TRPC6 + + + ND
TRPM2 − +? + ND
TRPM4 ND ND ND −
TRPM7 ± + ND ND
TRPV1 −⁎⁎ ⁎⁎⁎ ± +
TRPV2 +⁎⁎ −⁎⁎⁎ ND +
Jurkat MSC + − − +
⁎ Inhibited by ACA derivative, ﬂufenamic acid [31].
⁎⁎ Potentiates TRPV1 but inhibits TRPV2 [35].
⁎⁎⁎ Activates murine TRPV1 and 2 at N100 μM concentration [25]; human TRPV2 shows littleblock activate selected TRPs or 2-APB inhibit all channels in the TRPC
family, but act as an agonist for some TRPV channels, and combining
results of such analysis with available selectivity and current-voltage
relationship patterns for TRPs, a plausible identiﬁcation strategy can bekat cells in the present work.
R) SKF 96365 Permeability References
Ca2+/Na+ Mg2+
+? ~1 ND [63,73]
+ 1.6 +? [63,75]
+ 5 +? [26,32,70]
+ 0.5–1.6 + [21,32,50,69,70]
ND b0.05 ND [72]
ND⁎ 3 + [9,31,41]
ND 4 (heat)
10
(vaniloids)
+ [8,20]
+ 1–3 + [8,28,25,30,74]
+ ~1 + This study
or no sensitivity to 2-APB [28,47].
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selectivity and pharmacological proﬁle of TRPC, TRPV and TRPM channels
obtained on different experimental models, and then compared with our
data for the MSC in Jurkat lymphoblasts (Table 1).
Members of the TRPM family can be deﬁnitely excluded from possi-
ble candidates, due to their preference for monovalent (Na+) against
divalent (Ca2+) cations and to their sensitivity to ACA. TRPCs are
inhibited by 2-APB, but Jurkat MSCs were not (Fig. 5). Murine TRPV1–3
are stimulated by 2-APB, but human TRPV2 is hardly affected by this
compound [28,47]. Among TRPVs, TRPV1 is potentiated by Gd3+ and
can be therefore discarded [35]. TRPV4 and TRPV6, display a relatively
high and very high Ca2+/Na+ selectivity ratio, respectively [10,13].
Moreover, TRPV4mRNA is hardly detected in Jurkat cells [67]. However,
gross properties of the TRPV4 channels like I/V rectiﬁcation, sensitivity to
RR, lantanides, and SKF96365 [66,49,24] are reminiscent of properties of
the Jurkat MSC reported here, so TRPV4 cannot be fully discarded. The
best ﬁt so far, however, was the hTRPV2 channel, which complies with
all observed properties of the JurkatMSC (Table 1; see also the additional
argumentation below). For the sake of completeness, it should be noted
that there are other TRP subfamilies, whose presence has not been
detected in leukocytes so far. But TRPPs possess a relatively high selectiv-
ity for Ca2+ over Na+ and display inward rectiﬁcation [51], which
disqualiﬁes them as a molecular correlate for the MSC in Jurkat. On the
other hand, TRPA1 does not discriminate between Na+ and Ca2+ and
displays a similar rectiﬁcation to that shown in Fig. 3 [68,51]. It is similar-
ly affected by Gd3+, amiloride, and RR and is mechanosensitive, mediat-
ing the sensation of hearing and touch [46,5]. Yet, at zero external Ca2+,
single channel conductance of TRPA1 is about 100 pS [46] or several
times higher than that for the MSC in Jurkat cells (Fig. 3a).
In human leukocytes, relative expression of the TRPV2 is more than
by one order ofmagnitude higher as compared to TRPV1, 3 and 4 [60]. Di-
agram of human TRPV2 gene expression pattern was created [56] based
on previously undertaken transcriptome analysis [62], where a peculiar
expression of TRPV2 in some types of the cells of immune system was
demonstrated. TRPV2 mRNA decreased in the sequence: CD56− NK
cells N BDCA4+ dendritic cells N B-lymphoblasts and CD8+ cytotoxic
T cells N CD4+ helper T cells, CD14+ monocytes, CD33+myeloid
cells N CD19+ B cells N CD34+ hematopoietic stem cells. Several leuke-
mic/lymphoma cell lines were tested as well and all have shown a rela-
tively high level of TRPV2 expression: Raji (Burkitt's lymphoma) N K562
(chronic myelogenous leukemia) N HL60 (promyelocytic leukemia) N
Daudi (Burkitt's lymphoma) N MOLT4 (lymphoblastic leukemia).
Among all cell types revealed as TRPV2-positive in this study, patch
clamp experiments were reported only on K562 cells, where non-
selective Ca2+-permeable MSC with a conductance about 20 pS was
reported [61]. Unfortunately, no attempts were done to characterize
their sensitivity to drugs or pressure-dependence.
Our study is the ﬁrst report demonstrating the presence of cationic
Ca2+-permeable channels gated by plasma membrane deformation/
stretch in the Jurkat cell line. Detailed pharmacological analysis demon-
strates that, with a great likelihood, these channels are formed by TRPV2.
This conclusion was strengthened by the fact that in TRPV2 silenced
Jurkat cells membrane stretch did not activatemechanosensitive current
in a vast majority of cells. Taking into the account the importance of
mechanical stimuli both for healthy and leukemic T cells, ﬁndings
of the present study put forward further comparative research of the
mechanosensitivity in normal and leukemic lymphoid cells.
TRPV2 is a non-selective cation channel with Ca2+ permeability [8].
Therefore deformation and stretch of the lymphocyte plasmamembrane
duringmigration, cell–cell interaction events or cytokines secretionmay
result in its activation and contribute to the intracellular Ca2+ signaling.
In the recent review on the possible role of TRPV2 channels in immune
system [56], the patent application by Sauer and Jegla [57] is cited,
where silencing of the TRPV2 with shDNA in Jurkat cells impaired
T-cell receptor and CRAC-mediated Ca2+ signaling. These data sug-
gest TRPV2 as a feasible drug target for immunosuppression. TRPV2also plays critical role in the binding of particles and phagocytosis
by macrophages [38].
TRPV2 channels may be localized in endosomes, controlling
Ca2+-release, fusion, and endocytosis [55] and, when activated,
translocated to the plasma membrane [23]. Ca2+ inﬂux through
stretch-activated TRPV2 caused the degranulation in mast cells; these
MSCs have a similar dependence on applied pressure as the MSC in
this study (Fig. 2) and were sensitive to SKF96365 and RR [74]. Stretch
activation of the TRPV2 was demonstrated also in aortic myocytes and
alveolar cells [43,16] and in neurons, thus, controlling the axon out-
growth [59]. Pharmacology of TRPVs is extensively reviewed [65], but
no speciﬁc blocker/antagonist for TRPV2 has been reported so far. In ad-
dition to data of Table 1, TRPV2 was reported to be sensitive to
amiloride [65]. The pattern, reported here (Fig. 4a, c), i.e. afﬁnity and
voltage-dependence, was completely identical to that for intrinsic
MSC in oocytes of Xenopus (Fig. 7A in [33]). Within TRP channels,
amiloride was inefﬁcient with TRPC1 channels, but blocked, albeit in a
voltage-independent manner, different TRPP channels [12,1]. Also,
TRPA1 block by amiloride showed a very similar voltage-dependence
to that reported here [2]. In respect to the voltage-dependence
of Gd3+ block (Fig. 4b, c) we found a very similar pattern in case of
the TRPM-like MIC [18]. A permeable voltage-dependent block by Gd3+
and La3+ was reported for TRPM7, but this blockage required a
high, millimolar instead of micromolar, concentrations of lantanides
[41]. Sensitivity of the inward current through the Jurkat MSC to
Gd3+ coincides with that for the swelling-induced Ca2+ inﬂux
(SWAC) in immature T-cells [53].
Altered expression or abnormal activity of TRPV2 channelwas shown
to be associated with cancer, but its precise role in carcinogenesis is still
poorly understood. TRPV2 seems to be involved in different processes
which may promote tumor progression, but further studies are required
to determine its ability as a drug target or prognostic factor in each par-
ticular type of malignances. TRPV2 overexpression was evidenced in
patients with multiple myeloma [14]. In hepatocellular carcinoma, it
was rather associated with medium and well differentiated than poorly
differentiated tumors, where it was proposed as a prognostic marker
[37]. In prostate cancer, TRPV2 was shown to be involved in cancer cell
migration and invasion, and may be speciﬁcally implicated in the
progression to more aggressive phenotype [40]. Changes in proﬁling
namely increase in expression of full-length, when compared to short
splice-variant of TRPV2, were detected in progression toward high-
degree urothelial carcinoma [7]. On the other hand, TRPV2 was shown
to negatively control proliferation and resistance to Fas-induced apo-
ptosis of glioblastomamultiforme [44]. Although there is a lack of selec-
tive pharmacological tools for TRPV2, cannabidiol, the major non-
psychotropic cannabinoid compound derived from plant Cannabis
sativa [27], is a relatively selective TRPV2 agonist [52]. Whereas admin-
istration of cannabidiol was shown to induce apoptosis in human T24
bladder cancer cells due to continuous inﬂux of Ca2+ through TRPV2,
authors proposed it as a potential therapeutic target for human
urothelial carcinoma [71]. Some malignances, including glioblastoma
and multiple myeloma [45,42], are effectively sensitized to cytotoxic
chemotherapeutic agents by triggering of the TRPV2 channels. Bearing
in mind the predominant expression of TRPV2 in lymphocytes as com-
pared to the rest of the blood and to the smooth muscle, whereas its
expression in other tissues is very low [56], revelation of important
functions of this channel in lymphocyte physiology and leukemogenesis
is anticipated.Acknowledgments
Financial support by CONACyT, grants 12897 to OD and 220793 to IP
and FRABA (Universidad de Colima), grant 788/12 to IP is gratefully ac-
knowledged. We are thankful for Julio Cesar Villalvazo Guerrero for his
help in initial experiments.
58 I. Pottosin et al. / Biochimica et Biophysica Acta 1848 (2015) 51–59References
[1] C. Bai, A. Giamarchi, L. Rodat-Despoix, F. Padilla, T. Downs, L. Tsiokas, P. Delmas,
Formation of a new receptor-operated channel by heteromeric assembly of TRPP2
and TRPC1 subunits, EMBO Rep. 9 (2008) 472–479.
[2] T.G. Banke, Thedilated TRPA1 channel pore state is blockedby amiloride and analogues,
Brain Res. 1381 (2011) 21–30.
[3] M1. Bengtsson, A. Stahlberg, P. Rorsman, M. Kubista, Gene expression proﬁling in
single cells from the pancreatic islets of Langerhans reveals lognormal distribution
of mRNA levels, Genome Res. 15 (2005) 1388–1392.
[4] N. Bobak, S. Bittner, J. Andronic, S. Hartmann, F. Mühlpfordt, T. Schneider-Hohendorf,
K. Wolf, C. Schmelter, K. Göbel, P. Meuth, H. Zimmermann, F. Döring, E. Wischmeyer,
T. Budde, H. Wiendl, S.G. Meuth, V.L. Sukhorukov, Volume regulation of murine T
lymphocytes relies on voltage-dependent and two-pore domain potassium channels,
Biochim. Biophys. Acta 1808 (2011) 2036–2044.
[5] S.M. Brierley, J. Castro, A.M. Harrington, P.A. Hughes, A.J. Page, G.Y. Rychkov, L.A.
Blackshaw, TRPA1 contributes to speciﬁcmechanically activated currents and sensory
neuron mechanical hypersensitivity, J. Physiol. Lond. 589 (2011) 3575–3593.
[6] M.D. Cahalan, K.G. Chandy, The functional network of ion channels in T lymphocytes,
Immunol. Rev. 231 (2009) 59–87.
[7] S. Caprodossi, R. Lucciarini, C. Amantini, M. Nabissi, G. Canesin, P. Ballarini, A. Di
Spilimbergo, M.A. Cardarelli, L. Servi, G. Mammana, G. Santoni, Transient receptor
potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial
carcinoma of human bladder: correlation with the pathologic stage, Eur. Urol. 54
(2008) 612–620.
[8] M.J. Caterina, T.A. Rosen, M. Tominaga, A.J. Brake, D. Julius, A capsaicin-receptor
homologue with a high threshold for noxious heat, Nature 398 (1999) 436–441.
[9] R. Chokshi, P. Fruasaha, J.A. Kozak, 2-aminoethyl diphenyl borinate (2-APB) inhibits
TRPM7 channels through an intracellular acidiﬁcation mechanism, Channels (Austin)
6 (2012) 362–369.
[10] D.E. Clapham, D. Julius, C. Montell, G. Schultz, International Union of Pharmacology.
XLIX. Nomenclature and structure-function relationships of transient receptor
potential channels, Pharmacol. Rev. 57 (2005) 427–450.
[11] B. Coste, J. Mathur, M. Schmidt, T.J. Earley, S. Ranade, M.J. Petrus, A.E. Dubin, A.
Patapoutian, Piezo1 and Piezo2 are essential components of distinct mechanically
activated cation channels, Science 330 (2010) 55–60.
[12] X. Dai, A. Ramji, Y. Liu, Q. Li, E. Karpinski, X. Chen, Inhibition of TRPP3 channel by
amiloride and analogs, Mol. Pharmacol. 72 (2007) 1576–1585.
[13] W. Everaerts, B. Nilius, G. Owsianik, The vanilloid transient receptor potential channel
TRPV4: from structure to disease, Prog. Biophys. Mol. Biol. 103 (2010) 2–17.
[14] S. Fabris, K. Todoerti, L. Mosca, L. Agnelli, D. Intini, M. Lionetti, S. Guerneri, G.
Lambertenghi-Deliliers, F. Bertoni, A. Neri,Molecular and transcriptional characteriza-
tion of the novel 17p11.2-p12 amplicon in multiple myeloma, Genes Chromosomes
Cancer 46 (2007) 1109–1118.
[15] S. Feske, E.Y. Skolnik, M. Prakriya, Ion channels and transporters in lymphocyte
function and immunity, Nat. Rev. Immunol. 12 (2012) 532–547.
[16] G. Fois, O.Wittekindt, X. Zheng, E.T. Felder, P. Miklavc, M. Frick, P. Dietl, E. Felder, An
ultra fast detection method reveals strain-induced Ca2+ entry via TRPV2 in alveolar
type II cells, Biomech. Model. Mechanobiol. 11 (2012) 959–971.
[17] P.A. Gottlieb, F. Sachs, Piezo1: properties of a cation selective mechanical channel,
Channels 6 (2012) 214–219.
[18] A. Gwanyanya, B. Amuzescu, S.I. Zakharov, R. Macianskiene, K.R. Sipido, V.M. Bolotina,
J. Vereecke, K. Mubagwa, Magnesium-inhibited, TRPM6/7-like channel in cardiac
myocytes: permeation of divalent cations and pH-mediated regulation, J. Physiol.
559 (2004) 761–776.
[19] C. Harteneck, M. Gollasch, Pharmacological modulation of diacylglycerol-sensitive
TRPC3/6/7 channels, Curr. Pharm. Biotechnol. 12 (2011) 35–41.
[20] C. Harteneck, H. Frenzel, R. Kraft, N-(p-amylcinnamoyl)anthranilic acid (ACA): a
phospholipase A2 inhibitor and TRP channel blocker, Cardiovasc Drug Rev. 25
(2007) 61–75.
[21] C. Harteneck, C. Klose, D. Krautwurst, Synthetic modulators of TRP channel activity,
in: S. Islam (Ed.), Transient Receptor Potential Channels, Springer, 2011, pp. 87–106.
[22] E.S. Haswell, R. Phillips, D.C. Rees, Mechanosensitive channels: what can they do and
how do they do it? Structure 19 (2011) 1356–1369.
[23] E. Hisanaga, M. Nagasawa, K. Ueki, R.N. Kulkarni, M. Mori, I. Kojima, Regulation of
calcium-permeable TRPV2 channel by insulin in pancreatic beta-cells, Diabetes 58
(2009) 174–184.
[24] T.C. Ho, N.A. Horn, T. Huynh, L. Kelava, J.B. Lansman, Evidence TRPV4 contributes to
mechanosensitive ion channels in mouse skeletal muscle ﬁbers, Channels 6 (2012)
246–254.
[25] H.Z. Hu, Q. Gu, C. Wang, C.K. Colton, J. Tang, M. Kinoshita-Kawada, L.Y. Lee, J.D.
Wood, M.X. Zhu, 2-Aminoethoxydiphenyl borate is a common activator of TRPV1,
TRPV2, and TRPV3, J. Biol. Chem. 279 (2004) 35741–35748.
[26] R. Inoue, T. Okada, H. Onoue, Y.Hara, S. Shimizu, S.Naitoh, Y. Ito, Y.Mori, The transient
receptor potential protein homologue TRP6 is the essential component of vascular
α1-adrenoceptor-activated Ca2+-permeable cation channel, Circ. Res. 88 (2001)
325–332.
[27] A.A. Izzo, F. Borrelli, R. Capasso, V. Di Marzo, R. Mechoulam, Non-psychotropic plant
cannabinoids: new therapeutic opportunities from an ancient herb, Trends
Pharmacol. Sci. 30 (2009) 515–527.
[28] V. Juvin, A. Penna, J. Chemin, Y.L. Lin, F.A. Rassendren, Pharmacological characteriza-
tion and molecular determinants of the activation of transient receptor potential V2
channel orthologs by 2-aminoethoxydiphenyl borate, Mol. Pharmacol. 72 (2007)
1258–1268.
[29] R. Kakkar, H. Hei, S. Dobner, R.T. Lee, Interleukin 33 as a mechanically responsive
cytokine secreted by living cells, J. Biol. Chem. 287 (2012) 6941–6948.[30] M. Kanzaki, Y.Q. Zhang, H. Mashima, L. Li, H. Shibata, I. Kojima, Translocation of a
calcium-permeable cation channel induced by insulin-like growth factor-1, Nat.
Cell Biol. 1 (1999) 165–170.
[31] BJm Kim, K.J. Park, H.W. Kim, S. Choi, J.Y. Jun, I.Y. Chang, J. Jeon, I. So, S.J. Kim,
Identiﬁcation of TRPM7 channels in human intestinal interstitial cells of Cajal,
World J. Gastroenterol. 15 (2009) 5799–5804.
[32] R. Kraft, C. Grimm, H. Frenzel, C. Harteneck, Inhibition of TRPM2 cation channels by
N-(p-amylcinnamoyl)anthranilic acid, Br. J. Pharmacol. 148 (2006) 264–273.
[33] J.W. Lane, D.W. McBride Jr., O.P. Hamill, Amiloride block of the mechanosensitive
cation channel in Xenopus oocytes, J. Physiol. 441 (1991) 347–366.
[34] A. Lepple-Wienhues, I. Szabò, T. Laun, N.K. Kaba, E. Gulbins, F. Lang, The tyrosine
kinase p56lck mediates activation of swelling-induced chloride channels in lympho-
cytes, J. Cell Biol. 141 (1998) 281–286.
[35] A. Lefﬂer, R.M. Linte, C. Nau, P. Reeh, A. Babes, A high-threshold heat-activated
channel in cultured rat dorsal root ganglion neurons resembles TRPV2 and is
blocked by gadolinium, Eur. J. Neurosci. 26 (2007) 12–22.
[36] R.S. Lewis, P.E. Ross, M.D. Cahalan, Chloride channels activated by osmotic stress in T
lymphocytes, J. Gen. Physiol. 101 (1993) 801–826.
[37] G. Liu, C. Xie, F. Sun, X. Xu, Y. Yang, T. Zhang, Y. Deng, D. Wang, Z. Huang, L. Yang,
S. Huang, Q. Wang, G. Liu, D. Zhong, X. Miao, Clinical signiﬁcance of transient
receptor potential vanilloid 2 expression in human hepatocellular carcinoma,
Cancer Genet. Cytogenet. 197 (2010) 54–59.
[38] T.M. Link, U. Park, B.M. Vonakis, D.M. Raben, M.J. Soloski, M.J. Caterina, TRPV2 plays a
pivotal role in macrophage particle binding and phagocytosis, Nat. Immunol. 11
(2010) 232–239.
[39] B. Martinac, The ion channels to cytoskeleton connection as potential mechanism of
mechanosensitivity, Biochim. Biophys. Acta 1838 (2014) 682–691.
[40] M. Monet, V. Lehen'kyi, F. Gackiere, V. Firlej, M. Vandenberghe, M. Roudbaraki, D.
Gkika, A. Pourtier, G. Bidaux, C. Slomianny, P. Delcourt, F. Rassendren, J.P. Bergerat,
J. Ceraline, F. Cabon, S. Humez, N. Prevarskaya, Role of cationic channel TRPV2 in
promoting prostate cancer migration and progression to androgen resistance,
Cancer Res. 70 (2010) 1225–1235.
[41] M.K. Monteilh-Zoller, M.C. Hermosura, M.J. Nadler, A.M. Scharenberg, R. Penner, A.
Fleig, TRPM7 provides an ion channel mechanism for cellular entry of trace metal
ions, J. Gen. Physiol. 121 (2003) 49–60.
[42] M.B. Morelli, S. Liberati, C. Amantini, M. Nabissi, M. Santoni, V. Farfariello, G. Santoni,
Expression and function of the transient receptor potential ion channel family in the
hematologic malignancies, Curr. Mol. Pharmacol. 6 (2013) 137–148.
[43] K.Muraki, Y. Iwata, Y. Katanosaka, T. Ito, S. Ohya, M. Shikegawas, Y. Imaizumi, TRPV2
as a component of somatically sensitive cation chanels in murine aortic myocytes,
Circ. Res. 93 (2003) 829–838.
[44] M. Nabissi, M.B. Morelli, C. Amantini, V. Farfariello, L. Ricci-Vitiani, S. Caprodossi, A.
Arcella, M. Santoni, F. Giangaspero, R. DeMaria, G. Santoni, TRPV2 channel negatively
controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-
dependent manner, Carcinogenesis 31 (2010) 794–803.
[45] M. Nabissi, M.B. Morelli, M. Santoni, G. Santoni, Triggering of the TRPV2 channel
by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents,
Carcinogenesis 34 (2013) 48–57.
[46] K. Nagata, A. Duggan, G. Kumar, J. Garcia-Anoveros, Nociceptor and hair cell transducer
properties of TRPA1, a channel for pain and hearing, J. Neurosci. 25 (2005) 4052–4061.
[47] M.P. Neeper, Y. Liu, T.L. Hutchinson, Y. Wang, C.M. Flores, N. Qin, Activation proper-
ties of heterologously expressed mammalian TRPV2. Evidence for species depen-
dence, J. Biol. Chem. 282 (2007) 15894–15902.
[48] B. Nilius, E. Honoré, Sensing pressure with ion channels, Trends Neurosci. 35 (2012)
477–486.
[49] B. Nilius, J. Vriens, J. Prenen, G. Droogmans, T. Voets, TRPV4 calcium entry channel: a
paradigm for gating diversity, Am. J. Physiol. Cell Physiol. 286 (2004) C195–C205.
[50] B. Pang, D.H. Shin, K.S. Park, Y.J. Huh, J. Woo, Y. Zhang, T.M. Kang, K. Li, J. Kim, Differ-
ential pathways for calcium inﬂux activated by concanavalin A and CD3 stimulation
in Jurkat T cells, Pﬂugers Arch. - Eur. J. Physiol. 463 (2012) 309–318.
[51] M. Parnas, M. Peters, B. Minke, Biophysics of TRP channels, in: E.E. Egelman
Channels (Ed.), Comprehensive Biophysics, vol. 6, Elsevier B.V., 2012, pp. 68–107.
[52] N. Qin, M.P. Neeper, Y. Liu, et al., TRPV2 is activated by cannabidiol and mediates
CGRP release in cultured rat dorsal root ganglion neurons, J. Neurosci. 28 (2008)
6231–6238.
[53] P.E. Ross, M.D. Cahalan, Ca2+ inﬂux pathwaysmediated by swelling or stores depletion
in mouse thymocytes, J. Gen. Physiol. 106 (1995) 415–444.
[54] F. Sachs, Stretch-activated ion channels: what are they? Physiology (Bethesda) 25
(2010) 50–56.
[55] M. Saito, P.I. Hanson, P. Schlesinger, Luminal chloride-dependent activation of
endosome calcium channels: patch clamp study of enlarged endosomes, J. Biol.
Chem. 282 (2007) 27327–27333.
[56] G. Santoni, V. Farfariello, S. Liberati, M.B. Morelli, M. Nabissi, M. Santoni, C. Amantini,
The role of transient receptor potential vanilloid type-2 ion channels in innate and
adaptive immune responses, Front. Immunol. 4 (2013) 34.
[57] K. Sauer, T.J. Jegla (2006) Methods for Identifying T Cell Activation Modulating
Compounds. Patent ApplicationWO/2006/065613.
[58] T.D. Schmittgen, K.J. Livak, Analyzing real-time PCR data by the comparative CT
method, Nat. Protoc. 3 (2008) 1101–1108.
[59] K. Shibasaki, N. Murayama, K. Ono, Y. Ishizaki, M. Tominaga, TRPV2 enhances axon
outgrowth through its activation by membrane stretch in developing sensory and
motor neurons, J. Neurosci. 30 (2010) 4601–4612.
[60] G. Spinsanti, R. Zannoli, C. Panti, I. Ceccarelli, L. Marsili, V. Bachiocco, F. Frati,
A.M. Aloisi, Quantitative Real-Time PCR detection of TRPV1–4 gene expression
in human leukocytes from healthy and hyposensitive subjects, Mol. Pain 4
(2008) 51.
59I. Pottosin et al. / Biochimica et Biophysica Acta 1848 (2015) 51–59[61] A.V. Staruschenko, E.A. Vedernikova, Mechanosensitive cation channels in human
leukaemia cells: calcium permeation and blocking effect, J. Physiol. 541 (2002)
81–90.
[62] A.I. Su, T. Wiltshire, S. Batalov, H. Lapp, K.A. Ching, D. Block, J. Zhang, R. Soden, M.
Hayakawa, G. Kreiman, M.P. Cooke, J.R. Walker, J.B. Hogenesch, A gene atlas of the
mouse and human protein-encoding transcriptomes, Proc. Natl. Acad. Sci. U. S. A. 101
(2004) 6062–6067.
[63] V. Sydorenko, Y. Shuba, S. Thebault, M. Roudbaraki, G. Lepage, N. Prevarskaya, R.
Skryma, Receptor-coupled, DAG-gated Ca2+-permeable cationic channels in LNCaP
human prostate cancer epithelial cells, J. Physiol. 548 (2003) 823–836.
[64] C.S. Tremblay, B.J. Curtis, The clonal evolution of leukemic stem cells in T-cell actue
lymphoblastic leukemia, Curr. Opin. Hematol. 21 (2014) 320–325.
[65] J. Vriens, G. Appendino, B. Nilius, Pharmacology of vanilloid transient receptor potential
cation channels, Mol. Pharmacol. 75 (2009) 1262–1279.
[66] H. Watanabe, J. Vriens, S.H. Suh, C.D. Benham, G. Droogmans, B. Nilius, Heat-evoked
activation of TRPV4 channels in a HEK293 cell expression system and in native
mouse aorta endothelial cells, J. Biol. Chem. 277 (2002) 47044–47051.
[67] A.S. Wenning, K. Neblung, B. Strauss, M.J. Wolfs, A. Sappok, M. Hoth, E.C. Schwarz,
TRP expression pattern and the functional importance of TRPC3 in primary human
T-cells, Biochim. Biophys. Acta 1813 (2011) 412–423.
[68] L.J. Wu, T.B. Sweet, D.E. Clapham, International Union of Basic and Clinical Pharmacolo-
gy. LXXVI. Current progress in themammalian TRP ion channel family, Pharmacol. Rev.
62 (2010) 381–404.[69] R. Xia, Z. Mei, H. Mao, W. Yang, L. Dong, H. Bradley, D.J. Beech, L. Jiang, Identiﬁ-
cation of pore residues engaged in determining divalent cationic permeation in
transient receptor potential melastatin subtype channel 2, J. Biol. Chem. 283
(2008) 27426–27432.
[70] S. Xu, F. Zeng, G. Boulay, C. Grimm, C. Harteneck, D.J. Beech, Block of TRPC5
channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and
voltage-dependent effect, Br. J. Pharmacol. 145 (2005) 405–414.
[71] T. Yamada, T. Ueda, Y. Shibata, Y. Ikegami, M. Saito, Y. Ishida, S. Ugawa, K. Kohri,
S. Shimada, TRPV2 activation induces apoptotic cell death in human T24
bladder cancer cells: a potential therapeutic target for bladder cancer, Urology
76 (509) (2010) e1–e7.
[72] O.V. Yarishkin, E.M.Hwang, J.Y. Park, D. Kang, J. Han, S.G.Hong, Endogenous TRPM4-like
channel in Chinese hamster ovary (CHO) cells, Biochem. Biophys. Res. Commun. 369
(2008) 712–717.
[73] T.K. Zagranichnaya, X. Wu, M.L. Villereal, Endogenous TRPC1, TRPC3, and TRPC7
proteins combine to form native store-operated channels in HEK-293 cells, J. Biol.
Chem. 280 (2005) 29559–29569.
[74] D. Zhang, A. Spielmann, L. Wang, G. Ding, F. Huang, Q. Gu, W. Schwarz, Mast-cell
degranulation induced by physical stimuli involves the activation of transient-
receptor-potential channel TRPV2, Physiol. Res. 61 (2012) 113–124.
[75] C. Zitt, A.G. Obukhov, C. Strübing, A. Zobel, F. Kalkbrenner, A. Lückhoff, G. Schultz,
Expression of TRPC3 in Chinese hamster ovary cells results in calcium-activated cat-
ion currents not related to store depletion, J. Cell Biol. 138 (1997) 1333–1341.
